Copy For Citation
Morrad B., Görenek B., ,
European Journal of Arrhythmia & Electrophysiology, vol.01, no.01, pp.6-7, 2015 (Peer-Reviewed Journal)
Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in clinical practice. It may cause significant symptoms and impair both functional status and quality of life. Without therapeutic intervention, affected patients are at increased risk of mortality and morbidity, so AF places a major burden on healthcare systems. Many trials have been published on AF therapy in recent years. In this editorial, we will briefly discuss recent trials of AF therapies.